Recent Price Movement and Market Context
On 5 Mar 2026, TTK Healthcare Ltd. touched a new 52-week low price of Rs.867, continuing a downward trend that has persisted for five consecutive trading sessions. Over this period, the stock has lost 5.56% in value, underperforming its sector by 1.79% on the day. The stock’s day change registered a decline of 1.15%, while the broader Sensex index advanced by 0.6%, trading at 79,588.72 points after opening 414.29 points higher.
Despite the positive momentum in the market, led by mega-cap stocks and the NIFTY CPSE index hitting a 52-week high, TTK Healthcare’s shares have remained subdued. The stock is trading below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, signalling sustained bearish sentiment.
Long-Term Performance and Relative Comparison
Over the past year, TTK Healthcare Ltd. has delivered a negative return of 26.41%, a stark contrast to the Sensex’s 7.95% gain during the same period. The stock’s 52-week high was Rs.1402, highlighting the extent of the decline from its peak. Furthermore, the company’s performance has lagged behind the BSE500 index across multiple time frames, including the last three years, one year, and three months, indicating persistent underperformance relative to the broader market.
Rising fast and still accelerating! This Small Cap from FMCG sector is riding pure momentum right now. Jump in before the rally reaches its peak!
- - Accelerating price action
- - Pure momentum play
- - Pre-peak entry opportunity
Financial Metrics and Growth Analysis
TTK Healthcare’s long-term growth has been modest, with net sales increasing at an annualised rate of 6.99% over the last five years. Operating profit has grown at a slightly higher rate of 15.42% during the same period. However, recent quarterly results have been largely flat, with the December 2025 quarter showing no significant improvement in key financial indicators.
The company’s cash and cash equivalents stood at Rs.600.89 crores in the half-year period, marking the lowest level recorded in recent times. Additionally, the debtors turnover ratio for the half-year was 7.40 times, also at a low point, which may indicate slower collections or changes in credit terms.
Non-operating income accounted for 80.43% of the profit before tax in the latest quarter, suggesting that a substantial portion of earnings is derived from sources outside the core business operations.
Shareholding and Market Perception
Despite the company’s sizeable market presence, domestic mutual funds hold a minimal stake of just 0.01%. Given that domestic mutual funds typically conduct thorough research and due diligence, this limited exposure could reflect a cautious stance towards the stock’s valuation or business prospects.
Valuation and Profitability Metrics
TTK Healthcare maintains a low average debt-to-equity ratio of zero, indicating a debt-free capital structure. The return on equity (ROE) stands at 6.5%, which is moderate but below levels typically associated with high-growth companies. The stock’s price-to-book value ratio is 1.2, suggesting an attractive valuation relative to its book value, although it trades at a premium compared to its peers’ historical averages.
Over the past year, while the stock price has declined by 26.41%, the company’s profits have increased marginally by 2.4%. This disparity is reflected in a high price/earnings to growth (PEG) ratio of 7.6, indicating that the stock’s price may not be fully justified by its earnings growth rate.
TTK Healthcare Ltd. or something better? Our SwitchER feature analyzes this micro-cap Diversified stock and recommends superior alternatives based on fundamentals, momentum, and value!
- - SwitchER analysis complete
- - Superior alternatives found
- - Multi-parameter evaluation
Mojo Score and Rating Update
TTK Healthcare’s Mojo Score currently stands at 37.0, reflecting a cautious outlook. The company’s Mojo Grade was downgraded from Hold to Sell on 21 Jul 2025, signalling a reassessment of its medium to long-term prospects. The market capitalisation grade is rated 4, indicating a mid-sized company with moderate liquidity and market presence.
Summary of Key Concerns
The stock’s decline to Rs.867, its lowest level in 52 weeks, is underpinned by a combination of subdued sales growth, flat recent results, and a high reliance on non-operating income for profitability. The limited interest from domestic mutual funds and the stock’s underperformance relative to major indices further highlight challenges in market perception. While the company’s debt-free status and reasonable valuation metrics offer some stability, the overall financial and market data suggest a cautious environment for the stock.
Market and Sector Comparison
While TTK Healthcare has struggled, the broader diversified sector and mega-cap stocks have shown resilience, with the Sensex gaining 0.6% on the day and the NIFTY CPSE index reaching a new 52-week high. The Sensex is trading below its 50-day moving average, but the 50-day average remains above the 200-day average, indicating a mixed but generally positive market trend. This divergence emphasises the stock’s relative weakness within its sector and the wider market.
Conclusion
TTK Healthcare Ltd.’s fall to a 52-week low of Rs.867 reflects a period of subdued performance and cautious market sentiment. The stock’s underperformance against key benchmarks, combined with modest growth and valuation concerns, has contributed to this decline. The company’s financial metrics and market positioning suggest a need for careful monitoring as it navigates the current environment.
Limited Period Only. Get Started for only Rs. 16,999 - Get MojoOne for 2 Years + 1 Year Absolutely FREE! (72% Off) Get 72% Off →
